Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
46 Cards in this Set
- Front
- Back
Selegiline
|
Targets Parkinson's disease. Inhibits DA metabolism. Can intteract with SSRIs and cause hypertensive crisis.
|
|
Apomorphine
|
Emergency rescue drug for "off state" in Parkinson\s patients.
|
|
Thioridazine
|
Typical antipsychotic. Highly cholinergic. Highly sedative, but low rate of drug-induced Parkinsonism.
|
|
Domperidone
|
Anti-nausea. Originally antipsychotic.
|
|
Chloropromazine
|
Typical antipsychotic. Awful side effects.
|
|
Haloperidol
|
Typical antipsychotic. Low anticholinergic properties. Lightly sedative, strong motor effects.
|
|
Risperidone
|
Atypical antipsychotic. Also strong D2 antagonist. Less motor side effects than typical antipsychotics, but may elevate anxiety and depression.
|
|
Clozapine
|
Atypical antipsychotic. Also weak D2 antagonist. No motor side effects, helpful with tardive dyskinesia. Can cause agranulocytosis.
|
|
Olanzapine
|
Atypical antpsychotic. Also weak D2 antagonist. No motor side effectts or agranulocytosis,
|
|
Aripiprazole
|
Antipsychotic. Mild presynaptic D2 agonist and postsynaptic D2 antagonist. No motor side effects, potentially does not cause weight gain like other antipsychotics.
|
|
Phenobarbital
|
Antiepileptic (all types). Low dose barbituate, can be overly sedativee and mess with hepatic metabolism.
|
|
Clonazepam
|
Antiepileptic (all types). Benzodiazepine, less sedative than barbituates.
|
|
Lorazepam
|
Antiepileptic (status epilepticus only). Benzodiazepine, less sedative than barbituates.
|
|
Carbamazepine
|
Antiepileptic and bipolar disorder treatment. Blocks Na+ channels. Can cause ataxia, vertigo, and nystagmus.
|
|
Ethosuximide
|
Antiepileptic (absence seizures only). Blocks Ca2+ channels. Can cause gastrointestinal distress.
|
|
Cannabidiol ("Charlotte's Web")
|
Antiepileptic. Strain of mariuana with low THC content.
|
|
Clomipramine
|
Tricyclic antidepressant. NE reuptake inhibitor. Causes SLUDs and orthostatic hypotension. Also treats OCD and trichotillomania.
|
|
Phenelzine
|
MAO inhibitor antidepressant. Blocks NE, DA, and 5-HT metabolism. Interacts negatively with many foods.
|
|
Fluoxetine and Sertraline
|
SSRI antidepressants. Safest drugs for depression.
|
|
Venlafaxine
|
SNRI antidepressant. Inhibits 5-HT and NE metabolism. Must take 2-3 times per day.
|
|
Bupropion
|
Atypical antidepressant. Blocks NE and (potentially) DAreuptake, and is a noncompetitive nAchR antaagonist - can assist in recovery from nicotine addiction. Can cause nervousness and insomnia.
|
|
Asprin and Naproxen
|
Alzheimer's prophylactics NSAIDs.
|
|
Lovastatin
|
Alzheimer's prophylactic, statin. Decreaeses hypercholesterolemia.
|
|
Donepezil
|
Targets Alzheimer's disease. Reversible cholinesterase inhibitor (cholnomimetic). Cholinergic side effects, hepatotoxic interactions. Take 1 per day.
|
|
Rivastigmine
|
Targts Alaheimer's disease. Reversible cholinesterse inhibitor (cholinomimetic). No hepatotoxic interactions, but must take 2 per day.
|
|
Memantine
|
Targets Alzheimer's disease. Reversible NMDAr antagonist. Removed by large Glu pulses, allowing learning. Works well in combination with reversible cholinesterase inhibitors.
|
|
Levadopa (L-Dopa)
|
Targets Parkinson's disease. DA precursor, but causes nausea due to lack of absorption into brain. Can cause psychosis.
|
|
Sinemet
|
Targets Parkinson's disease. L-Dopa with Carbidopa. Does not cause nausea, may cause psychosis.
|
|
Entacapone
|
Targets Parkinson's disease. Peripheral COMT inhibitor, prevents eliination of L-Dopa, increasing half life and bioavailability of Sinemet. Particularly useful for "on-off" effects.
|
|
Scopolamine
|
Targets vertigo. Originally anticholinergic Parkinson's drug.
|
|
Benzatropine
|
Targets Parkinson's disease. Anticholinergic. Low TI, SLUDs.
|
|
Bromocriptine
|
Targets Parkinson's disease. D2 agonist, early monotherapy or late adunct therapy. May cause dyskinesia or hallycinations.
|
|
Amantidine
|
Targets Parkinson's disease. Stimulates DA relase, blocks Glu release. Early monotherapy or late adunct therapy.
|
|
Lithium
|
Targets bipolar disorder/mania. Mechanism unknown, most likely alters 5-HT and NE transission.
|
|
Flumazenil
|
Reverses benzodiazepine effects. Causes increased anxiety.
|
|
Midazolam and Triazolam
|
Sedatives. Short-acting benzodiazepines, few side effects.
|
|
Secobarbital
|
Sedative. Mid-to long-lasting barbituate, lethal in high doses.
|
|
Diphenhydramine
|
Sedative. Antihistamine, anticholinergic. Very safe.
|
|
Busiprone
|
Anxiolyti. 5-HT1Ar agonist. Takes weeks to work, but no side effects.
|
|
Zolpidem ("Z-Drugs")
|
Non-anxiolytic sedative. Acts on site of benzodiazepines. Can cause mild psychological dependence.
|
|
Melatonin
|
Sedative, mild hypnotic. Not always pure when sold as dietary supplement, but useful against jet-lag.
|
|
Thiopental
|
Anesthetic. Short-acting barbitate, IV inection. Can suppress respiration and heartbeat.
|
|
Ketamine
|
Anesthetic. NMDAr modulator, similar to PCP. Causes dissociative anesthesia.
|
|
Nitrous oxide
|
Anesthetic. Inhaant. Analgesic, useful for potentiation of other analgesics. Can OD.
|
|
Halothane
|
Inhalant anesthetic. Causes hangover effects, risk of liver damage.
|
|
Isoflurane
|
Inhalant anesthetic. Safer than others, suppresses respiration and heartbear less.
|